HELAXA
LIVE

Serial Number

79367170

Owner

Helaxa GmbH & Co. KG

Attorney

KATRIN LEWERTOFF

Filing Date

Dec 3, 2022

Add to watchlist:

No watchlists yet
View on USPTO

HELAXA Trademark

Serial Number: 79367170 • Registration: 7962927

HELAXA is a trademark filed by Helaxa GmbH & Co. KG on December 3, 2022. The trademark is classified under Class 1 (Chemicals), Class 3 (Cosmetics & Cleaning), Class 5 (Pharmaceuticals), Class 42 (Computer & Scientific). The application is currently registered and active.

Owner Contact Info

Helaxa GmbH & Co. KG (3 trademarks)

Nordkanalstraße 28

Entity Type: 99

Trademark Details

Filing Date

December 3, 2022

Registration Date

September 30, 2025

Published for Opposition

August 6, 2024

Goods & Services

Chemicals for use in industry and science; biological preparations for use in industry and science; all the aforementioned goods not in relation to food and food production

Scientific and technological services and research and design relating thereto, namely, scientific research in the medical and pharmaceutical fields and design relating thereto, namely, design and testing of new products for others; industrial analysis and research services in the medical and pharmaceutical fields; industrial design; research and development of new products for others; medical research services; technical research services in the medical and pharmaceutical fields; quality control for others; chemical analysis; medical and scientific research, namely, conducting clinical trials for others; chemical laboratories; technological research in the medical and pharmaceutical fields; scientific research

Non- medical cosmetics

Pharmaceuticals, namely, heparin, heparinoids, sodium salts, heparin sodium, heparin calcium, heparin lithium, stearalkonium heparin; medical preparations, namely, heparin, heparinoids, sodium salts, heparin sodium, heparin calcium, heparin lithium, stearalkonium heparin; veterinary preparations, namely, heparin, heparinoids, sodium salts, heparin sodium, heparin calcium, heparin lithium, stearalkonium heparin; pharmaceutical preparations, namely, heparin, heparinoids, sodium salts, heparin sodium, heparin calcium, heparin lithium, stearalkonium heparin; medicinal healthcare preparations, namely, heparin, heparinoids, sodium salts, heparin sodium, heparin calcium, heparin lithium, stearalkonium heparin; medicinal preparations and substances, namely, heparin, heparinoids, sodium salts, heparin sodium, heparin calcium, heparin lithium, stearalkonium heparin; medicines for human purposes, namely, heparin, heparinoids, sodium salts, heparin sodium, heparin calcium, heparin lithium, stearalkonium heparin; medicines for veterinary purposes, namely, heparin, heparinoids, sodium salts, heparin sodium, heparin calcium, heparin lithium, stearalkonium heparin; nutritional supplements for human purposes; nutritional supplements for veterinary use; dietetic foods adapted for medical purposes

Filing History

FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
Dec 30, 2025 FICR
NEW REPRESENTATIVE AT IB RECEIVED
Nov 14, 2025 NREP
LIMITATION OF GOODS RECEIVED FROM IB
Oct 24, 2025 LIMG
NOTICE OF REGISTRATION CONFIRMATION EMAILED
Sep 30, 2025 NRCC
REGISTERED-PRINCIPAL REGISTER
Sep 30, 2025 R.PR
TTAB RELEASE CASE TO TRADEMARKS
Sep 9, 2025 TMBN
OPPOSITION TERMINATED NO. 999999
Sep 9, 2025 OP.T
OPPOSITION DISMISSED NO. 999999
Sep 9, 2025 OP.D
LIMITATION OF GOODS RECEIVED FROM IB
Sep 5, 2025 LIMG
REFUSAL PROCESSED BY IB
Mar 1, 2025 RFNP
EXTENSION OF TIME TO OPPOSE PROCESS - TERMINATED
Feb 3, 2025 ETOP
OPPOSITION INSTITUTED NO. 999999
Feb 3, 2025 OP.I
OPPOSITION NOTICE (IB REFUSAL) SENT TO IB
Feb 1, 2025 OPNS
OPPOSITION NOTICE (IB REFUSAL) CREATED
Feb 1, 2025 OPNC
NOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB
Sep 20, 2024 OPNX
EXTENSION OF TIME TO OPPOSE RECEIVED
Sep 5, 2024 ETOF
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
Sep 4, 2024 OPNS
NOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB
Sep 4, 2024 OPNR
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Aug 6, 2024 NPUB
PUBLISHED FOR OPPOSITION
Aug 6, 2024 PUBO
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Jul 17, 2024 NONP
APPROVED FOR PUB - PRINCIPAL REGISTER
Jul 1, 2024 CNSA
TEAS/EMAIL CORRESPONDENCE ENTERED
Jun 27, 2024 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Jun 27, 2024 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Jun 27, 2024 TROA
TEAS CHANGE OF CORRESPONDENCE RECEIVED
Jun 4, 2024 TCCA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Jun 4, 2024 ARAA
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Jun 4, 2024 REAP
REFUSAL PROCESSED BY IB
Mar 26, 2024 RFNP
TEAS CHANGE OF CORRESPONDENCE RECEIVED
Mar 16, 2024 TCCA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Mar 16, 2024 ARAA
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Mar 16, 2024 REAP
APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Mar 16, 2024 CHAN
TEAS CHANGE OF OWNER ADDRESS RECEIVED
Mar 16, 2024 COAR
NOTIFICATION OF NON-FINAL ACTION E-MAILED
Feb 26, 2024 GNRN
NON-FINAL ACTION E-MAILED
Feb 26, 2024 GNRT
NON-FINAL ACTION WRITTEN
Feb 26, 2024 CNRT
TEAS/EMAIL CORRESPONDENCE ENTERED
Feb 6, 2024 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Feb 5, 2024 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Feb 5, 2024 TROA
REFUSAL PROCESSED BY IB
Oct 25, 2023 RFNT
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
Sep 29, 2023 RFCS
LIMITATION FROM THE IB - REQUEST EXAM REVIEW
Sep 29, 2023 LIME
REFUSAL PROCESSED BY MPU
Sep 29, 2023 RFRR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
Sep 16, 2023 RFCR
NON-FINAL ACTION WRITTEN
Sep 15, 2023 CNRT
ASSIGNED TO EXAMINER
Sep 12, 2023 DOCK
LIMITATION OF GOODS RECEIVED FROM IB
Sep 2, 2023 LIMG
APPLICATION FILING RECEIPT MAILED
Apr 14, 2023 MAFR
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Apr 10, 2023 NWOS
SN ASSIGNED FOR SECT 66A APPL FROM IB
Apr 7, 2023 REPR